DEREK J. MAETZOLD - 10 Jan 2022 Form 4 Insider Report for CASTLE BIOSCIENCES INC (CSTL)

Role
Pres. & Chief Exec. Officer, Director
Signature
/s/ Greg Acosta, Attorney-in-fact
Issuer symbol
CSTL
Transactions as of
10 Jan 2022
Net transactions value
$0
Form type
4
Filing time
20 Jan 2022, 16:16:39 UTC
Previous filing
14 Dec 2021
Next filing
28 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSTL Common Stock Gift $0 -122,181 -100% $0.000000* 0 10 Jan 2022 By DJM Grantor Retained Annuity Trust No. 1 F1, F2
holding CSTL Common Stock 135,226 10 Jan 2022 Direct F1, F3
holding CSTL Common Stock 100,000 10 Jan 2022 By DJM Grantor Retained Annuity Trust No. 2 F3
holding CSTL Common Stock 75,000 10 Jan 2022 By DJM Grantor Retained Annuity Trust No. 3 F4
holding CSTL Common Stock 137,965 10 Jan 2022 By Derek Maetzold 2020 Irrevocable Trust F5
holding CSTL Common Stock 150,567 10 Jan 2022 By The Maetzold Descendants 2020 Trust F6
holding CSTL Common Stock 30,545 10 Jan 2022 By The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold F2
holding CSTL Common Stock 30,545 10 Jan 2022 By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold F2
holding CSTL Common Stock 30,546 10 Jan 2022 By The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk F2
holding CSTL Common Stock 30,545 10 Jan 2022 By The Maetzold 2018 Remainder Trust FBO John Derek Maetzold F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 5, 2022, the Reporting Person transferred 5,547 shares of Castle Biosciences, Inc. common stock to his direct holdings.
F2 On January 10, 2022, the Reporting Person transferred 122,181 shares collectively of Castle Biosciences, Inc. common stock to The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold, The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk, and The Maetzold 2018 Remainder Trust FBO John Derek Maetzold, all of which the Reporting Person is the trustee and his children are the beneficiaries.
F3 On February 26, 2021, the Reporting Person transferred 100,000 shares of Castle Biosciences, Inc. common stock that was previously not reported to the DJM Grantor Retained Annuity Trust No. 2 of which the Reporting Person is trustee and beneficiary.
F4 Held by DJM Grantor Retained Annuity Trust No. 3 of which the Reporting Person is the trustee and beneficiary.
F5 Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries.
F6 Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries.